Skip to Main Content

Author Details

Mateusz Koptyra
Children's Hospital of Philadelphia
2004
28
15
PMIDPaper TitleJournal TitlePublished Year
36335802The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.Neoplasia2023
36335802The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.Neoplasia2023
37337080Radiomics for characterization of the glioma immune microenvironment.NPJ Precis Oncol2023
37189250A metagenomic analysis of the virome of inverted papilloma and squamous cell carcinoma.Int Forum Allergy Rhinol2023
37001527Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities.Cancer Cell2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
37189250A metagenomic analysis of the virome of inverted papilloma and squamous cell carcinoma.Int Forum Allergy Rhinol2023
37337080Radiomics for characterization of the glioma immune microenvironment.NPJ Precis Oncol2023
37001527Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities.Cancer Cell2023
34510780Targeted gene expression profiling of inverted papilloma and squamous cell carcinoma.Int Forum Allergy Rhinol2022
34510780Targeted gene expression profiling of inverted papilloma and squamous cell carcinoma.Int Forum Allergy Rhinol2022
31613963Pediatric high-grade glioma resources from the Children's Brain Tumor Tissue Consortium.Neuro Oncol2020
31613963Pediatric high-grade glioma resources from the Children's Brain Tumor Tissue Consortium.Neuro Oncol2020
34128919Informatics Methods and Infrastructure Needed to Study Factors Associated with High Incidence of Pediatric Brain and Central Nervous System Tumors in Kentucky.J Registry Manag2020
33119584A transcriptome-based classifier to determine molecular subtypes in medulloblastoma.PLoS Comput Biol2020
34128919Informatics Methods and Infrastructure Needed to Study Factors Associated with High Incidence of Pediatric Brain and Central Nervous System Tumors in Kentucky.J Registry Manag2020
33119584A transcriptome-based classifier to determine molecular subtypes in medulloblastoma.PLoS Comput Biol2020
25557916Crk and CrkL are required for cell transformation by v-fos and v-ras.Mol Carcinog2016
25557916Crk and CrkL are required for cell transformation by v-fos and v-ras.Mol Carcinog2016
26864341Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases.Blood2016
27807028Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL).J Biol Chem2016
27807028Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL).J Biol Chem2016
26864341Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases.Blood2016
25552366Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate Cancer.Mol Cancer Ther2015
25552366Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate Cancer.Mol Cancer Ther2015
23543457Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells.Blood2013
23543457Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells.Blood2013
22411871Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors.Blood2012
22411871Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors.Blood2012
21704724Signal transducer and activator of transcription 5a/b: biomarker and therapeutic target in prostate and breast cancer.Int J Biochem Cell Biol2011
21519342Monoubiquitinated Fanconi anemia D2 (FANCD2-Ub) is required for BCR-ABL1 kinase-induced leukemogenesis.Leukemia2011
21704724Signal transducer and activator of transcription 5a/b: biomarker and therapeutic target in prostate and breast cancer.Int J Biochem Cell Biol2011
21693657Imatinib sensitivity in BCR-ABL1-positive chronic myeloid leukemia cells is regulated by the remaining normal ABL1 allele.Cancer Res2011
21519342Monoubiquitinated Fanconi anemia D2 (FANCD2-Ub) is required for BCR-ABL1 kinase-induced leukemogenesis.Leukemia2011
21693657Imatinib sensitivity in BCR-ABL1-positive chronic myeloid leukemia cells is regulated by the remaining normal ABL1 allele.Cancer Res2011
18401418BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress.Leukemia2008
18413724BCR/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations.Cancer Res2008
18401418BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress.Leukemia2008
18757400BCR/ABL and other kinases from chronic myeloproliferative disorders stimulate single-strand annealing, an unfaithful DNA double-strand break repair.Cancer Res2008
18757400BCR/ABL and other kinases from chronic myeloproliferative disorders stimulate single-strand annealing, an unfaithful DNA double-strand break repair.Cancer Res2008
18413724BCR/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations.Cancer Res2008
16297667BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells.DNA Repair (Amst)2006
16572421IRS-1-Rad51 nuclear interaction sensitizes JCV T-antigen positive medulloblastoma cells to genotoxic treatment.Int J Cancer2006
16687921ATR-Chk1 axis protects BCR/ABL leukemia cells from the lethal effect of DNA double-strand breaks.Cell Cycle2006
16297667BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells.DNA Repair (Amst)2006
16527898BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance.Blood2006
16527898BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance.Blood2006
16572421IRS-1-Rad51 nuclear interaction sensitizes JCV T-antigen positive medulloblastoma cells to genotoxic treatment.Int J Cancer2006
16687921ATR-Chk1 axis protects BCR/ABL leukemia cells from the lethal effect of DNA double-strand breaks.Cell Cycle2006
  • 1 - 50 of 56

Recommended Authors

Jordi Carreras Puigvert
Department of Pharmaceutical Biosciences, Uppsala University
Career Start Year 2009
Number of shared co-authors 0
Vadym Zaberezhnyy
University of Colorado Anschutz Medical Campus
Career Start Year 2009
Number of shared co-authors 0
Alexandre Puissant
Universite de Paris, INSERM, CNRS
Career Start Year 2007
Number of shared co-authors 0
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 0
Anna M Eiring
Texas Tech University Health Sciences Center at El Paso
Career Start Year 2004
Number of shared co-authors 2
Christopher C Porter
Emory University School of Medicine
Career Start Year 2003
Number of shared co-authors 1
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Career Start Year 2002
Number of shared co-authors 3
Yi-Jue Zhao
The First Affiliated Hospital of Guangxi Medical University
Career Start Year 1998
Number of shared co-authors 1
Sandra Burkett
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 0
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Shiaw-Yih Lin
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 0
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 0
Yongjin Li
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 4
Christopher J Bakkenist
UPMC Hillman Cancer Center, University of Pittsburgh
Career Start Year 1994
Number of shared co-authors 0
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1993
Number of shared co-authors 0
Seishi Ogawa
Kyoto University
Career Start Year 1993
Number of shared co-authors 1
Andrei Goga
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 0
Bill H Chang
Oregon Health and Science University
Career Start Year 1993
Number of shared co-authors 0
John Easton
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 3
Kara Johnson
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1991
Number of shared co-authors 0
James DeGregori
University of Colorado Anschutz Medical Campus
Career Start Year 1991
Number of shared co-authors 0
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1991
Number of shared co-authors 1
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 3
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 3
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 6
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 3
Feyruz V Rassool
University of Maryland Greenebaum Comprehensive Cancer Center
Career Start Year 1984
Number of shared co-authors 0
Brian J Druker
Oregon Health & Science University
Career Start Year 1978
Number of shared co-authors 3
Alex Look
Dana-Farber Cancer Institute
Career Start Year 1975
Number of shared co-authors 3

Collaborators

Adam C Resnick
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 8
Phillip B Storm
Children's Hospital of Philadelphia
Co-authored papers 8
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 4
Rishi R Lulla
Hasbro Children's Hospital, Brown University.
Co-authored papers 3
Allison P Heath
Children's Hospital of Philadelphia
Co-authored papers 3
Komal S Rathi
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 3
Mariarita Santi
Children's Hospital of Philadelphia
Co-authored papers 3
Angela J Waanders
Ann & Robert H. Lurie Children's Hospital
Co-authored papers 3
Javad Nazarian
USA University of Zurich
Co-authored papers 3
Kristina A Cole
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 3
Jennifer L Mason
Children's Hospital of Philadelphia
Co-authored papers 3
Sharon J Diskin
Children's Hospital of Philadelphia
Co-authored papers 3
Valérie Baubet
Co-authored papers 3
Lamiya Tauhid
Co-authored papers 2
Jalal B Jalaly
Co-authored papers 2
Michael A Kohanski
Co-authored papers 2
Brian R Rood
Brain Tumor Institute, Children's National Hospital
Co-authored papers 2
Zalman Vaksman
Children's Hospital of Philadelphia
Co-authored papers 2
Namrata Choudhari
Co-authored papers 2
Noam A Cohen
Co-authored papers 2
Edward C Kuan
Co-authored papers 2
Adam A Kraya
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 2
Krutika S Gaonkar
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 2
Heba Ijaz
Co-authored papers 2
Shannon Robins
Children's Hospital of Philadelphia
Co-authored papers 2
Sabine Mueller
University Children's Hospital Zurich
Co-authored papers 2
Jason E Cain
Co-authored papers 2
Michael D Prados
University of California san francisco
Co-authored papers 2
Yuankun Zhu
Children's Hospital of Philadelphia
Co-authored papers 2
Peter Papagiannopoulos
Co-authored papers 2
Release 1.2